Viral loads in dual infection with HIV-1 and cytomegalovirus

被引:6
作者
Boriskin, YS
Sharland, M
Dalton, R
duMont, G
Booth, JC
机构
[1] Univ London St Georges Hosp, Sch Med, Dept Med Microbiol, London SW17 0RE, England
[2] Univ London St Georges Hosp, Sch Med, Paediat Infect Dis Unit, London SW17 0RE, England
[3] Univ London St Georges Hosp, Sch Med, Dept Ophthalmol, London SW17 0RE, England
[4] St Thomas Hosp, Dept Paediat, London SE1 7EH, England
关键词
cytomegalovirus; human immunodeficiency virus; viral load;
D O I
10.1136/adc.80.2.132
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective-A one year study of the relation between cytomegalovirus (CMV) and human immunodeficiency virus (HIV) viral loads in a cohort of children with vertically acquired HIV-1 infection. Design-Comparative analysis of viral load measurements for CMV and HIV-1 in peripheral blood leucocytes (PBLs) of individual children in relation to age and clinical staging. Methods-Nested polymerase chain reaction (PCR) was used to measure HIV-1 proviral DNA and CMV genomic DNA IN PBLs of 56 children. Results-The CMV load was highest in 0-2 year old HIV positive children with stage C disease (range, 1-7143 copies/100 ng DNA; median, 125) and was significantly lower in older children. Although higher in young children, HIV-1 viral load did not show the same marked reduction with age that is seen with CMV Over a one year period, testing of serial samples for both viruses in a subgroup of children revealed a discordant relation between viral loads for CMV and HIV-1. Conclusions-CMV viral load falls much faster than HIV viral load in dually infected children. Screening for clinical CMV disease is most likely to be of benefit in children under 2 years of age with stage C disease. In the few children studied, levels of CMV and HIV replication appear to be independent.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 38 条
[31]  
SEI S, 1996, J INFECT DIS, V173, P485
[32]   BLOOD MONOCYTES FROM MOST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS DO NOT CARRY PROVIRAL DNA [J].
SHEN, YN ;
RUDNIK, J ;
CASSOL, S ;
DROUIN, J ;
CAMERON, W ;
IZAGUIRRE, CA ;
FILION, LG .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (05) :531-537
[33]  
SODERBERG C, 1993, J VIROL, V67, P3166
[34]   DETECTION OF HUMAN CYTOMEGALOVIRUS IN PLASMA OF AIDS PATIENTS DURING ACUTE VISCERAL DISEASE BY DNA AMPLIFICATION [J].
SPECTOR, SA ;
MERRILL, R ;
WOLF, D ;
DANKNER, WM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) :2359-2365
[35]   Virus load as a marker of disease progression in HIV-infected children [J].
Tetali, S ;
Abrams, E ;
Bakshi, S ;
Paul, M ;
Oyaizu, N ;
Pahwa, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (08) :669-675
[36]   INTERACTIONS OF HUMAN CYTOMEGALOVIRUS WITH LEUKOCYTES INVIVO - ANALYSIS BY INSITU HYBRIDIZATION [J].
TURTINEN, LW ;
SALTZMAN, R ;
JORDAN, MC ;
HAASE, AT .
MICROBIAL PATHOGENESIS, 1987, 3 (04) :287-297
[37]   EVALUATION OF PROVIRAL COPY NUMBER AND PLASMA RNA LEVEL AS EARLY INDICATORS OF PROGRESSION IN HIV-1 INFECTION - CORRELATION WITH VIROLOGICAL AND IMMUNOLOGICAL MARKERS OF DISEASE [J].
VERHOFSTEDE, C ;
RENIERS, S ;
VANWANZEELE, F ;
PLUM, J .
AIDS, 1994, 8 (10) :1421-1427
[38]   HUMAN CYTOMEGALOVIRUS IMMEDIATE-EARLY AND LATE TRANSCRIPTS ARE EXPRESSED IN ALL MAJOR LEUKOCYTE POPULATIONS IN-VIVO [J].
VONLAER, D ;
SERR, A ;
MEYERKONIG, U ;
KIRSTE, G ;
HUFERT, FT ;
HALLER, O .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :365-370